APP Users: If unable to download, please re-install our APP.
Only logged in User can create notes
Only logged in User can create notes

General Studies 3 >> Science & Technology

audio may take few seconds to load

MARBURG

MARBURG

Source: indianexpress

Context:

The first two cases of the Marburg virus disease, highly infectious diseases like Ebola, have been confirmed officially by Ghana after test results were verified by a Senegal laboratory.

History

  • Marburg was first detected in 1967 after simultaneous outbreaks in Marburg and Frankfurt in Germany, Belgrade, and Serbia.
  • This outbreak is only the second time that the disease has been detected in West Africa.
  • As it was first detected in Marburg, it got its name.

Marburg

  • As per WHO, Marburg Virus Disease (MVD), is a severe, often fatal hemorrhagic fever.
  • Earlier it was known as Marburg hemorrhagic fever.
  • Marburg, like Ebola, is a filovirus and both diseases are clinically similar.

Hosts

  • Rousettus fruit bats are considered the natural hosts for the Marburg virus.
  • According to WHO, African green monkeys imported from Uganda were the source of the first human infection.
  • It was first detected in 1967 after simultaneous outbreaks in Marburg & Frankfurt in Germany, Belgrade Serbia.
  • The disease has an average fatality rate of around 50%.
  • It may be as low as 24% and as high as 88% depending on virus strain and case management.

Symptoms

  • The onset of symptoms may begin anytime in between 2-21 days.
  • MVD can manifest itself in the form of high fever, muscle aches and severe headaches.
  • Around the 3rd day, patients report abdominal pain, vomiting, severe watery diarrhoea and cramping.
  • The appearance of patients is described as “ghost-like” with deep-set eyes, expressionless faces, and extreme lethargy.
  • Between 5-7 days, patients report bleeding from the nose, gums and blood appearing in vomits and faeces.
  • Severe blood loss leads to death, often between 8-9 days after symptoms begin.
 
 

Challenges of MVD

  • It is difficult to clinically distinguish from malaria, typhoid fever and other viral hemorrhagic fevers.
  • It is confirmed by lab testing of samples, like coronavirus and Ebola are extreme biohazard risks.
  • There is no approved antiviral treatment or vaccine for MVD till now.
  • It can be managed with supportive care.
  • As per WHO guidelines, rehydration with oral or intravenous fluids and treatment of specific symptoms can help prevent death.

Share to Social